PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation
出版年份 2017 全文链接
标题
PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CANCER
Volume 141, Issue 7, Pages 1402-1412
出版商
Wiley
发表日期
2017-06-15
DOI
10.1002/ijc.30834
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients
- (2016) Arun Satelli et al. Scientific Reports
- Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells
- (2015) Abdullah Alsuliman et al. Molecular Cancer
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma
- (2015) Patcharee Ritprajak et al. ORAL ONCOLOGY
- Proteomic analysis of Class IV lupus nephritis
- (2014) Ayodele Alaiya et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Molecular and Cellular Heterogeneity in Breast Cancer
- (2013) Ashley G. Rivenbark et al. AMERICAN JOURNAL OF PATHOLOGY
- Profiling of normal and malignant breast tissue show CD44high/CD24lowphenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers
- (2013) Hazem Ghebeh et al. BMC CANCER
- Quantification of residual risk of relapse in breast cancer patients optimally treated
- (2013) Maria Vittoria Dieci et al. BREAST
- Protein Phosphatase 2A and DNA-dependent Protein Kinase Are Involved in Mediating Rapamycin-induced Akt Phosphorylation
- (2013) Yikun Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The emerging multiple roles of nuclear Akt
- (2012) Alberto M. Martelli et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Reciprocal Regulation of Akt and Oct4 Promotes the Self-Renewal and Survival of Embryonal Carcinoma Cells
- (2012) Yuanji Lin et al. MOLECULAR CELL
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Phosphorylation regulates human OCT4
- (2012) J. Brumbaugh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fascin Is a Key Regulator of Breast Cancer Invasion That Acts via the Modification of Metastasis-Associated Molecules
- (2011) Monther Al-Alwan et al. PLoS One
- Roles of the Polycomb group proteins in stem cells and cancer
- (2011) H Richly et al. Cell Death & Disease
- Using a Stem Cell-Based Signature to Guide Therapeutic Selection in Cancer
- (2010) I. Shats et al. CANCER RESEARCH
- Targeting breast cancer stem cells
- (2010) Sean P. McDermott et al. Molecular Oncology
- ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
- (2009) Yifang Hu et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition
- (2009) M. Breuleux et al. MOLECULAR CANCER THERAPEUTICS
- B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells
- (2008) T. Azuma et al. BLOOD
- FOXP3+ Tregs and B7-H1+/PD-1+T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy
- (2008) Hazem Ghebeh et al. BMC CANCER
- Suppression of mTOR complex 2-dependent AKT phosphorylation in melanoma cells by combined treatment with rapamycin and LY294002
- (2008) J. Werzowa et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficient tumour formation by single human melanoma cells
- (2008) Elsa Quintana et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started